Research and experimental development on natural sciences and engineering
DIAGNOSTRIX AS
Revenue 2024
NOK 238,000
Operating profit
NOK −3.8m
Equity
NOK −1.3m
Incorporated
2020
Share capital
NOK 42,000
Key figures · 2024
Current ratio
0.14
Equity ratio
-16.3%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -1620.2% | |
| Net margin (%%) | -1629.5% | |
| Return on assets (%%) | -49.9% | |
| Likviditet | ||
| Current ratio | 0.14 | |
| Working capital | −7.5m | |
| Soliditet | ||
| Equity ratio (%%) | -16.3% | |
| Debt-to-equity ratio | -7.12 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.